Emmanuel Papadakis from Deutsche Bank retains his positive opinion on the stock with a Buy rating. The target price remains set at GBX 13000. | April 28, 2023
AstraZeneca : 2023 has started with strong momentum marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
The Food and Drug Administration s Oncologic Drugs Advisory Committee has recognised a favourable benefit risk profile for AstraZeneca and MSD s Lynparza plus abiraterone and. | April 28, 2023
AstraZeneca PLC on Thursday said revenue decreased in the first quarter of the year as Covid-19 related sales dropped, but pretax profit surged.
The Cambridge, UK-based pharmaceutical firm reported. | April 27, 2023